647 filings
Page 3 of 33
8-K
t9rnte3
17 Aug 20
Other Events
4:41pm
NT 10-Q
pib2e64lnouh6dsfguqq
10 Aug 20
Notice of late quarterly filing
9:35pm
8-K
jek zez7h23
6 Aug 20
Amag Pharmaceuticals Announces Second Quarter 2020 Financial Results
7:06am
8-K
3twdn3 4fl2w
27 Jul 20
Amag Pharmaceuticals Completes Divestment of Women’s Health Assets
7:38am
8-K
4rjvy1y 1gu
23 Jul 20
Amag Pharmaceuticals and Norgine B.V. Enter into Exclusive Licensing Agreement to Commercialize Ciraparantag In Europe, Australia and New Zealand
9:24am
8-K
zrno6v2t
11 Jun 20
Amag Pharmaceuticals Announces Leadership Changes
7:13am
8-K
rgqqd74r2au
4 Jun 20
Submission of Matters to a Vote of Security Holders
4:41pm
8-K
gk6px 3a234ho1
21 May 20
Amag Pharmaceuticals Completes Sale of Its Rights to Intrarosa® to Millicent Pharma for Up to $125 Million
9:34pm
8-K
rwsl0
11 May 20
Amag Pharmaceuticals Announces First Quarter 2020 Financial Results
7:18am
CT ORDER
fo9nl
6 May 20
Confidential treatment order
2:51pm
CT ORDER
4u1j0vra32yt
6 May 20
Confidential treatment order
2:51pm
CT ORDER
qafiib9bph8
6 May 20
Confidential treatment order
2:50pm
CT ORDER
v2hkl740p0e5ltaq1qg
6 May 20
Confidential treatment order
2:49pm
8-K
lx8 ec4he34uuot
28 Apr 20
AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer
7:34am
8-K
ldajlb8iuj9
16 Apr 20
Amag Pharmaceuticals Provides COVID-19 Company Update
7:45am